Evaluation of HFCWO using The Vest System for Treatment of Non-Cystic Fibrosis Bronchiectasis in the home setting

Brief description of study

The study will be a non-blinded prospective Randomized Control Trial (RCT) pilot study with subjects requiring airway clearance therapy randomized to Oscillating Positive Expiratory Pressure (OPEP) therapy as the control group and High Frequency Chest Wall Oscillation (HFCWO) therapy as the intervention group. The objective is to evaluate the use of The Vest® System to treat Non-Cystic Fibrosis Bronchiectasis (NCFBE) patients in the home setting with the primary endpoint of frequency of acute exacerbations of bronchiectasis.


Clinical Study Identifier: s19-01067
ClinicalTrials.gov Identifier: NCT04017312
Principal Investigator: Ashwin Basavaraj
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.